Evidence map›Paper›PMID 12200530›Full record

ReviewThorax2002

Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema.

J C Hogg, R M Senior

Abstract readReview
In one paragraph

Review in Thorax, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Lung volume reduction surgery for diffuse emphysema.The Cochrane database of systematic reviews · 2016
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. MAP2K1 dampens cigarette smoke-induced inflammation via suppression of type I interferon pathway activation.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. S100A8 Protects Human Primary Alveolar Type II Cells against Injury and Emphysema.American journal of respiratory cell and molecular biology · 2019
    Article
  16. Matrix metalloproteinases in emphysema.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  17. Review
  18. Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease.Oxidative medicine and cellular longevity · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J C HoggThe University of British Columbia McDonald Research Laboratory, St Paul's Hospital, Vancouver, Canada. JHogg@mrl.ubc.ca
R M Senior

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathology and pathogenesis of emphysema are reviewed, with particular reference to the proteinase-antiproteinase hypothesis.

Indexed as

EndopeptidasesHumansLeukocytesMetalloendopeptidasesPulmonary Disease, Chronic ObstructivePulmonary EmphysemaEndopeptidasesMetalloendopeptidases

Identifiers

PMID12200530
PMCPMC1746435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.